SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Hoyer who wrote (295)4/28/2000 8:11:00 AM
From: biowa of 557
 
Gary,

"You can't call it a cure" until the children are older and the disease doesn't return, Anderson cautioned

A key point. Another is that this seems to be the kind of leap straight to the final test approach that got French Anderson into hot water. I much prefer, the more methodical one step at a time approach, for instance, that TGEN has followed with the CF candidate.

In addition, what is described here is ex vivo gene therapy, while much of what TGEN is working on is in vivo, a trickier issue.

That said, this is excellent news, especially for those infants and their families. And yes indeed it does show the brilliant potential of gene therapy.

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext